Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27307459
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Methicillin-Resistant Staphylococcus aureus Control in the 21st Century:
Laboratory Involvement Affecting Disease Impact and Economic Benefit from Large
Population Studies
#MMPMID27307459
Peterson LR
; Schora DM
J Clin Microbiol
2016[Nov]; 54
(11
): 2647-2654
PMID27307459
show ga
Methicillin-resistant Staphylococcus aureus (MRSA) infection is a global health
care problem. Large studies (e.g., >25,000 patients) show that active
surveillance testing (AST) followed by contact precautions for positive patients
is an effective approach for MRSA disease control. With this approach, the
clinical laboratory will be asked to select what AST method(s) to use and to
provide data monitoring outcomes of the infection prevention interventions. This
minireview summarizes evidence for MRSA disease control, reviews the involvement
of the laboratory, and provides examples of how to undertake a program cost
analysis. Health care organizations with total MRSA clinical infections of
>0.3/1,000 patient days or bloodstream infections of >0.03/1,000 patient days
should implement a MRSA control plan.
|*Epidemiological Monitoring
[MESH]
|Carrier State/*diagnosis/microbiology
[MESH]
|Clinical Laboratory Techniques/*methods
[MESH]
|Disease Transmission, Infectious/*prevention & control
[MESH]
free
free
free
